Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genomics Laboratory, |
RCV003458187 | SCV004177158 | uncertain significance | Van Maldergem syndrome 2 | 2023-08-07 | criteria provided, single submitter | clinical testing | The FAT4 c.13247T>A ( p.Leu4416Gln) variant was identified at near heterozygous allelic fraction. This variant, to our knowledge, has not been reported in the medical literature. The FAT4 c.13247T>A ( p.Leu4416Gln) variant is absent from the general population (gnomAD v.2.1.1), indicating it is not a common variant. Computational predictors are conflicting as to the impact of this variant on the FAT4 function. Due to limited information and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |
Fulgent Genetics, |
RCV005030034 | SCV005657641 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-02-29 | criteria provided, single submitter | clinical testing |